Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- Zelenskyy calls for air defense systems as allies meet
- Columbia leadership rebuked by faculty panel for police crackdown on protesters
- Gaza student protest in Paris sees tense standoff with Israel supporters
- Von der Leyen to avoid TikTok in very ‘personal’ campaign
- Bolt lobbying revelations: Estonia official says human error behind missing correspondence
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
Subscribe to our jobletter!